SBC Medical Group Holdings earnings release, May 14, 2026

SBC Medical Group Holdings Inc (SBC) · Form 8-K, Item 2.02 · Filed · SEC filing

SBC Medical Group Holdings Announces First Quarter 2026 Financial Results

IRVINE, Calif. --SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced its financial results for the three months ended March 31, 2026.

First Quarter 2026 Highlights

• Total revenues were $43 million, representing a 9% year-over-year decrease.

• Net income attributable to SBC Medical Group Holdings Incorporated was $11 million, representing a 47% year-over-year decrease.

Net income margin was 26% for the first quarter of 2026, representing a year-over-year decrease of 19 percentage points.

• Earnings per share, which is defined as net income attributable to the Company divided by the weighted average number of outstanding shares, was $0.11 for the three months ended March 31, 2026, representing a 48% year-over-year decrease.

• EBITDA¹, which is calculated by adding depreciation and amortization expense to income from operations was $18 million, representing a 26% year-over-year decrease.

EBITDA margin¹ was 43% for the first quarter of 2026, representing a year-over-year decrease of 10 percentage points.

• Return on equity², which is defined as net income attributable to the Company divided by the average shareholders' equity as of March 31, 2026, was 18% representing a year-over-year decrease of 23 percentage points.

• Number of franchise locations³ was 284 as of March 31, 2026, representing an increase of 33 locations from March 31, 2025.

• Number of customers⁴ in the last twelve months ended March 31, 2026, was 6.76 million, representing a 10% year-over-year increase.

• Repeat rate for customers⁵ who visited franchisee’s clinics twice or more was 72%.

Yoshiyuki Aikawa, Chairman and Chief Executive Officer of SBC Medical, said,

“

For the first quarter of fiscal year 2026, SBC Medical reported revenue of $43 million, representing a 9% year-over-year decline. This decrease was primarily attributable to a strategic structural reform implemented in April 2025, involving a revision of the franchise fee structure. Excluding this structural change, the performance of our core business remained solid. In terms of profitability, our net income margin was 26%, and our EBITDA margin remained at a high level of 43%.

Looking ahead, we will continue to promote our multi-brand strategy in the aesthetic dermatology field, expand our non-aesthetic medical business, and strengthen our operational foundation in overseas markets. In addition, we will pursue opportunities in the longevity market and further enhance our services through the utilization of AI, with the goal of building a sustainable and continuously growing healthcare platform.”¹

EBITDA and EBITDA margin are non-GAAP financial measures. For more information on non-GAAP financial measures, please see the section “Use of Non-GAAP Financial Measures” and the table captioned “Unaudited Reconciliations of GAAP and Non-GAAP Results.”²

Return on equity is presented on an annualized basis.³

The figure includes locations of the franchising of SBC brand clinics, Rize Clinic, Gorilla Clinic, AHH Clinic, JUN CLINIC, OrangeTwist.⁴

The customer count includes customers of SBC brand clinics, Rize Clinic, Gorilla Clinic, AHH Clinic, and JUN CLINIC. The applicable periods are from April 1, 2025 to March 31, 2026.⁵

The figures include franchised SBC brand clinics, Rize Clinic, Gorilla Clinic, AHH Clinic, and JUN Clinic, excluding free counseling. The percentages represent customers who visited our franchisees' clinics twice or more. Please note that the unique counts and repeat rates for AHH clinics and JUN clinics are estimated based on the ratios of SBC brand clinics, Rize clinics, and Gorilla clinics.

Conference Call

The Company will hold a conference call on Thursday, May 14, 2026, at 8:30 a.m. Eastern Time (or Thursday, May 14, 2026, at 9:30 p.m. Japan Time) to discuss the financial results for the first quarter ended March 31, 2026. A question‑and‑answer session with analysts and investors will follow the prepared remarks.

Please register in advance of the conference using the link provided below. https://zoom.us/webinar/register/WN_6RZgrwsUREiRpAmBBGTikA

It will automatically direct you to the registration page of “ 1Q 2026 Earning Call ”. Please follow the steps to enter your registration details, then click “Submit.”. Upon registration, you will be able to access the dedicated Conference Call viewing site. In addition to viewing the conference call, this site provides access to information about the speakers as well as past investor relations materials.

Additionally, the earnings release, accompanying slides, and an archived webcast of this conference call will be available at the Company’s Investor Relations website at https://ir.sbc-holdings.com/

About SBC Medical

SBC Medical Group Holdings Incorporated is a Medical Services Organization providing management support across a wide range of healthcare fields, including advanced aesthetic healthcare, dermatology, orthopedics, fertility treatment, gynecology, dentistry, alopecia treatment (AGA), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose “Contributing to the well-being of people around the world through medical innovation,” SBC Medical Group Holdings Incorporated continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.... (trunnformation, visit https://sbc-holdings.com/en

For more insights and updates from SBC Medical, follow us on

LinkedIn.

Use of Non-GAAP Financial Measures

The Company uses non-GAAP measures, such as EBITDA and EBITDA margin, in evaluating its operating results and for financial and operational decision-making purposes. The Company believes that the non-GAAP financial measures help identify underlying trends in its business. The Company believes that the non-GAAP financial measures provide useful information about the Company’s results of operations, enhance the overall understanding of the Company’s past performance and future prospects and allow for greater visibility with respect to key metrics used by the Company’s management in its financial and operational decision-making.

The non-GAAP financial measures are not defined under U.S. GAAP and are not presented in accordance with U.S. GAAP. The non-GAAP financial measures have limitations as analytical tools, and when assessing the Company’s operating performance, cash flows or liquidity, investors should not consider them in isolation, or as a substitute for net income (loss), net income margin, cash flows provided by operating activities, or other consolidated statements of operations and cash flows data prepared in accordance with U.S. GAAP.

The Company mitigates these limitations by reconciling the non-GAAP financial measures to the most comparable U.S. GAAP performance measures, all of which should be considered when evaluating the Company’s performance.

For more information on the non-GAAP financial measures, please see the table captioned “Unaudited Reconciliations of GAAP and Non-GAAP Results.”

Financial statements

Income Statement

For the Three Months Ended March 31, — UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME

For the Three Months Ended March 31, – 2026For the Three Months Ended March 31, – 2025
Revenues, net – related parties37,955,06045,257,145
Revenues, net5,105,5022,071,556
Total revenues, net43,060,56247,328,701
Cost of revenues (including cost of revenues from related parties of $124,389 and $3,456,928 for the three months ended March 31, 2026 and 2025, respectively)12,713,8289,595,617
Gross profit30,346,73437,733,084
Operating expenses:Selling, general and administrative expenses (including selling, general and administrative expenses from related parties of $343,393 and nil for the three months ended March 31, 2026 and 2025, respectively)12,626,71913,531,010
Operating expenses:Total operating expenses12,626,71913,531,010
Operating expenses:Income from operations17,720,01524,202,074
Other income (expenses):Interest income121,36955,333
Other income (expenses):Interest expense-114,806-6,207
Other income (expenses):Foreign currency exchange gain (loss), net861,678-1,058,526
Other income (expenses):Other income491,564151,328
Other income (expenses):Other expenses-223,209-638,733
Other income (expenses):Gain on redemption of life insurance policies8,746,138
Other income (expenses):Total other income1,136,5967,249,333
Other income (expenses):Income before income taxes18,856,61131,451,407
Other income (expenses):Income tax expense7,527,5919,959,457
Other income (expenses):Net income11,329,02021,491,950
Other income (expenses):Less: net income (loss) attributable to non-controlling interests20,949-10,496
Other income (expenses):Net income attributable to SBC Medical Group Holdings Incorporated11,308,07121,502,446
Other comprehensive income (loss):Foreign currency translation adjustment-4,249,5499,808,327
Other comprehensive income (loss):Total comprehensive income7,079,47131,300,277
Other comprehensive income (loss):Less: comprehensive income (loss) attributable to non-controlling interests18,295-36,832
Other comprehensive income (loss):Comprehensive income attributable to SBC Medical Group Holdings Incorporated7,061,17631,337,109
Net income per share attributable to SBC Medical Group Holdings IncorporatedBasic and diluted0.110.21
Weighted average shares outstandingBasic and diluted102,576,943103,276,637

Income Statement

For the Three Months Ended March 31, — Unaudited Reconciliations of GAAP and Non-GAAP Results

For the Three Months Ended March 31, – 2026For the Three Months Ended March 31, – 2025
Total Revenues, net43,060,56247,328,701
Net income attributable to SBC Medical Group Holdings Incorporated11,308,07121,502,446
Net income margin26.0%45.0%
Income from operations17,720,01524,202,074
Depreciation and amortization expense670,434628,304
EBITDA18,390,44924,830,378
EBITDA margin43.0%52.0%

Balance Sheet

March 31, 2026 — UNAUDITED CONSOLIDATED BALANCE SHEETS

March 31, 2026December 31, 2025
Current assets:Cash and cash equivalents167,305,095163,773,838
Current assets:Accounts receivable2,980,1932,388,021
Current assets:Accounts receivable – related parties33,784,53227,511,730
Current assets:Inventories2,323,8802,792,617
Current assets:Short-term investments – related parties313,865319,193
Current assets:Finance lease receivables, current – related parties13,326,15012,832,355
Current assets:Income tax recoverable1,173,9131,175,510
Current assets:Customer loans receivable, current6,659,8378,705,999
Current assets:Prepaid expenses and other current assets10,912,71711,724,852
Current assets:Total current assets238,780,182231,224,115
Non-current assets:Property and equipment, net7,287,3697,539,392
Non-current assets:Intangible assets, net47,152,28547,742,888
Non-current assets:Long-term investments, net1,198,5831,299,366
Non-current assets:Equity method investments20,312,64220,312,642
Non-current assets:Goodwill, net15,398,04915,432,061
Non-current assets:Finance lease receivables, non-current – related parties12,548,80013,746,513
Non-current assets:Operating lease right-of-use assets11,084,1988,366,569
Non-current assets:Finance lease right-of-use assets392,118450,874
Non-current assets:Deferred tax assets4,975,6294,014,294
Non-current assets:Customer loans receivable, non-current3,454,9694,824,977
Non-current assets:Long-term prepayments705,430393,270
Non-current assets:Long-term investments in MCs – related parties17,539,56417,837,293
Non-current assets:Other assets7,189,7587,263,692
Non-current assets:Total non-current assets149,239,394149,223,831
Non-current assets:Total assets388,019,576380,447,946
Current liabilities:Accounts payable19,168,07216,988,384
Current liabilities:Accounts payable – related parties527,624651,463
Current liabilities:Bank and other borrowings, current8,987,1189,099,046
Current liabilities:Advances from customers1,011,2491,415,762
Current liabilities:Advances from customers – related parties4,217,0575,357,221
Current liabilities:Income tax payable8,450,4408,821,853
Current liabilities:Operating lease liabilities, current5,521,3714,416,960
Current liabilities:Finance lease liabilities, current118,297132,946
Current liabilities:Accrued liabilities and other current liabilities11,896,37111,544,695
Current liabilities:Due to related party2,670,0162,692,673
Current liabilities:Total current liabilities62,567,61561,121,003

Balance Sheet

March 31, 2026 — UNAUDITED CONSOLIDATED BALANCE SHEETS — (Continued)

March 31, 2026December 31, 2025
Non-current liabilities:Bank and other borrowings, non-current31,447,90033,734,438
Non-current liabilities:Deferred tax liabilities16,215,81616,374,832
Non-current liabilities:Operating lease liabilities, non-current5,731,5144,136,257
Non-current liabilities:Finance lease liabilities, non-current93,600116,527
Non-current liabilities:Other liabilities1,578,9541,660,183
Non-current liabilities:Total non-current liabilities55,067,78456,022,237
Non-current liabilities:Total liabilities117,635,399117,143,240
Stockholders’ equity:Common stock ($0.0001 par value, 400,000,000 shares authorized, 103,881,251 shares issued, and 102,576,943 shares outstanding as of March 31, 2026 and December 31, 2025)10,38810,388
Stockholders’ equity:Additional paid-in capital72,867,42472,867,424
Stockholders’ equity:Treasury stock (at cost, 1,304,308 shares as of March 31, 2026 and December 31, 2025)-7,749,997-7,749,997
Stockholders’ equity:Retained earnings251,756,691240,448,620
Stockholders’ equity:Accumulated other comprehensive loss-61,541,134-57,294,239
Stockholders’ equity:Total SBC Medical Group Holdings Incorporated stockholders’ equity255,343,372248,282,196
Stockholders’ equity:Non-controlling interests15,040,80515,022,510
Stockholders’ equity:Total stockholders’ equity270,384,177263,304,706
Stockholders’ equity:Total liabilities and stockholders’ equity388,019,576380,447,946

Cash Flow

For the Three Months Ended March 31, — UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Three Months Ended March 31, – 2026For the Three Months Ended March 31, – 2025
CASH FLOWS FROM OPERATING ACTIVITIESNet income11,329,02021,491,950
Adjustments to reconcile net income to net cash provided by operating activities:Depreciation and amortization expense670,434628,304
Adjustments to reconcile net income to net cash provided by operating activities:Non-cash lease expense1,420,824985,184
Adjustments to reconcile net income to net cash provided by operating activities:Provision for (reversal of) credit losses-31,35325,102
Adjustments to reconcile net income to net cash provided by operating activities:Fair value change of long-term investments80,301140,581
Adjustments to reconcile net income to net cash provided by operating activities:Gain on redemption of life insurance policies-8,746,138
Adjustments to reconcile net income to net cash provided by operating activities:Gain on disposal of property and equipment-12,375
Adjustments to reconcile net income to net cash provided by operating activities:Deferred income taxes-1,086,4737,016,227
Changes in operating assets and liabilities:Accounts receivable-627,606-147,925
Changes in operating assets and liabilities:Accounts receivable - related parties-6,821,339-295,505
Changes in operating assets and liabilities:Inventories442,643-124,279
Changes in operating assets and liabilities:Finance lease receivables - related parties264,252-2,779,253
Changes in operating assets and liabilities:Customer loans receivable3,270,3474,501,760
Changes in operating assets and liabilities:Prepaid expenses and other current assets629,253-3,150,243
Changes in operating assets and liabilities:Long-term prepayments31,59298,164
Changes in operating assets and liabilities:Other assets-66,265318,351
Changes in operating assets and liabilities:Accounts payable2,484,4373,235,017
Changes in operating assets and liabilities:Accounts payable - related parties-114,689441,481
Changes in operating assets and liabilities:Notes payables - related parties-548,077
Changes in operating assets and liabilities:Advances from customers-386,997-328,791
Changes in operating assets and liabilities:Advances from customers - related parties-1,066,776-2,114,829
Changes in operating assets and liabilities:Income tax payable-245,955-17,635,239
Changes in operating assets and liabilities:Operating lease liabilities-1,424,716-1,036,605
Changes in operating assets and liabilities:Accrued liabilities and other current liabilities543,41263,764
Changes in operating assets and liabilities:Other liabilities-62,408-98,005
Changes in operating assets and liabilities:NET CASH PROVIDED BY OPERATING ACTIVITIES9,231,9381,928,621
CASH FLOWS FROM INVESTING ACTIVITIESPurchase of property and equipment-124,995-253,725
CASH FLOWS FROM INVESTING ACTIVITIESPrepayments for property and equipment-423,870-501,253
CASH FLOWS FROM INVESTING ACTIVITIESPurchase of long-term investments-635,145
CASH FLOWS FROM INVESTING ACTIVITIESLong-term loans to others-12,783
CASH FLOWS FROM INVESTING ACTIVITIESRepayments from related parties70,000
CASH FLOWS FROM INVESTING ACTIVITIESRepayments from others20,84030,680
CASH FLOWS FROM INVESTING ACTIVITIESProceeds from disposal of property and equipment323,419
CASH FLOWS FROM INVESTING ACTIVITIESNET CASH USED IN INVESTING ACTIVITIES-528,025-978,807
CASH FLOWS FROM FINANCING ACTIVITIESBorrowings from related parties15,000
CASH FLOWS FROM FINANCING ACTIVITIESRepayments of bank and other borrowings-1,782,479-55,873
CASH FLOWS FROM FINANCING ACTIVITIESRepayments of finance lease liabilities-37,278-223,454
CASH FLOWS FROM FINANCING ACTIVITIESRepayments to related parties-22,657-16,053
CASH FLOWS FROM FINANCING ACTIVITIESNET CASH USED IN FINANCING ACTIVITIES-1,842,414-280,380
CASH FLOWS FROM FINANCING ACTIVITIESEffect of exchange rate changes-3,330,2426,342,297
Full release

Forward-Looking Statements

This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company’s beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company’s control. These forward-looking statements reflect the Company’s current views with respect to, among other things, the Company’s financial performance; growth in revenue and earnings; business prospects and opportunities; and capital deployment plans and liquidity. In some cases, forward-looking statements can be identified by the use of words such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management’s current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading “Risk Factors” and elsewhere in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”), which are accessible on the SEC’s website at www.sec.gov.

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · SBC Medical Group Holdings earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.